216 - Mini-Oral Abstracts Session
Biomarkers & monitoring

Monday September 12, 2022 | 11:35 to 13:05
Room: E
Track: Basic and Translational Sciences

Description

For attending this session, you can claim 1.5 EACCME credits

Presentations

Dr. Minnie M. Sarwal, United States
QSant, a multi-analyte urine-based test, types the injury of DGF and its recovery

Tarek Alhamad, United States
Acute Tubular Injury And Necrosis Do Not Lead To Meaningful Elevations In Donor-derived Cell-free DNA (dd-cfDNA)

Enver Akalin, United States
Enhanced Histological Yield And Actionable Findings When Biopsy Is Guided By Donor-derived Cell-free DNA (dd-cfDNA)

Enver Akalin, United States
Wide Spectrum Of Molecular Injury Highlights Heterogeneity Of Banff Tubulitis And Interstitial Inflammation Lesions

Dr. Jayanthi Chandar, United States
Beneficial Addition of Donor-derived cell-free DNA Testing in Pediatric Kidney Transplantation

Dr. Ji-Young Kim, Canada
Regulatory T cell biomarkers identify patients at risk of developing acute cellular rejection in the first year following heart transplantation

Prof. TainĂ¡ V Sandes-Freitas, Brazil
The immunohistochemical expression of endothelial activation biomarkers is a potential tool to predict kidney allograft outcomes

Dr. John Friedewald, United States
Dynamic kidney graft failure risk prediction using serial donor derived cell free DNA

Ms. Ivana Sedej, Slovenia
Urinary extracellular vesicle DNA cargo reflects kidney allograft injury



© 2024 TTS 2022